Results 61 to 70 of about 23,386 (218)

Peritoneal Carcinomatosis in Patients with Locally Advanced Colon Cancer: Literature Review

Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Aim: to analyse and systematise available literature data on the diagnosis and treatment of patients with locally advanced colon cancer with peritoneal carcinomatosis.Key points.
S. Yu. Trishchenkov, O. V. Levina, V. M. Nekoval, V. V. Balaban, P. V. Tsarkov   +4 more
doaj   +1 more source

2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations

Gastroenterology Research and Practice, 2018
Ovarian cancer peritoneal carcinomatosis requires a multimodal-treatment approach. Current treatment considerations are analyzed in this update and include the management of recurrent malignant ascites and the understanding of its pathophysiology, the ...
Evgenia Halkia, George Chrelias, Charalambos Chrelias, Jesus Esquivel   +3 more
doaj   +1 more source

Immunotherapy of Peritoneal Carcinomatosis with the Antibody Catumaxomab in Colon, Gastric, or Pancreatic Cancer: An Open-Label, Multicenter, Phase I/II Trial [PDF]

, 2011
Background: Peritoneal carcinomatosis (PC) is common in gastrointestinal (GI) cancer and there is no effective standard treatment. We investigated the tolerability and maximum tolerated dose (MTD) of the trifunctional antibody catumaxomab in patients ...
Grützner, Klaus-Uwe, Heiss, Markus M., Hennig, Michael, Jauch, Karl-Walter, Jäger, Michael, Lindhofer, Horst, Lordick, Florian, Peschel, Christian, Rüttinger, Dominik, Schemanski, Oliver C., Ströhlein, Michael A.   +10 more
core   +1 more source

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

International Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg, Cathrine L. Lorentzen, Marie C. W. Westergaard, Trine Z. Iversen, Troels H. Borch, Marco Donia, Sigrid M. Mannering, Stine E. W. Banke, Özcan Met, Inge Marie Svane   +9 more
wiley   +1 more source

The Many Faces of the Angry Peritoneum

Diagnostics
The peritoneum is a thin membrane that lines the abdominal cavity and covers the abdominal organs. It serves as a conduit for the spread of various pathological processes, including gas and fluid collections, inflammation, infections, and neoplastic ...
Maria Chiara Ambrosetti, Matilde Bariani, Giulia Angela Zamboni, Riccardo Valletta, Matteo Bonatti   +4 more
doaj   +1 more source

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis

Case Reports in Gastroenterology, 2012
Peritoneal carcinomatosis is a well-known factor of poor prognosis in patients with digestive adenocarcinomas. Peritoneal dissemination may also occur in midgut well-differentiated neuroendocrine tumors, but its influence on survival is ill-defined.
Louis de Mestier, Cindy Neuzillet, Olivia Hentic, Reza Kianmanesh, Pascal Hammel, Philippe Ruszniewski   +5 more
doaj   +1 more source

Postoperative Weight Gain, Due to Fluid Retention After Ovarian Cancer Surgery—How Much Is too Much?

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Postoperative complications after cytoreductive surgery in ovarian cancer patients are associated with impaired survival. Here, we investigated the association between postoperative weight gain due to fluid retention and the development of complications and anastomotic leakage (AL).
Eva K. Egger, Melisa Delen, Hanno Matthaei, Laura Tascon Padron, Carolin Schröder, Milka Marinova, Dominique Koensgen, Alexander Mustea   +7 more
wiley   +1 more source

Magnetic Resonance Imaging of Peritoneal Carcinomatosis: Evaluation of High b-Value Computed Diffusion-Weighted Imaging

Current Oncology, 2022
Over the last few years, diffusion-weighted imaging (DWI) has become increasingly relevant in the diagnostic assessment of peritoneal carcinomatosis. The aim of this study was to investigate the benefits of high-b DWI (c-DWI) compared to standard DWI in ...
Maxime Ablefoni, Jakob Leonhardi, Constantin Ehrengut, Matthias Mehdorn, Robert Sucher, Ines Gockel, Timm Denecke, Hans-Jonas Meyer   +7 more
doaj   +1 more source

Inflammatory Markers may Determine Postoperative Complications in Cases of Peritoneal Carcinomatosis of Ovarian Origin Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives This study aimed to evaluate the ability of perioperative inflammatory markers to discriminate postoperative complications within 6 months in patients with ovarian cancer–related peritoneal metastasis undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Donmez Mustafa, Bisgin Tayfun, Manoglu Berke, Sokmen Selman, Sensoy Basoglu Ecem, Boztas Nilay, Ozgul Ozkardesler Sevda   +6 more
wiley   +1 more source

Peritoneal thickening: It's not always carcinomatosis

Radiology Case Reports, 2021
The peritoneal pseudotumor localization of tuberculosis is a rare clinical form, representing 1 to 3% of extrapulmonary site of tuberculosis. It represents the sixth most common extra pulmonary site of tuberculosis.
Amalik Sanae, Resident, El Agouri Hajar, Resident, Khouchoua Selma, Resident, Jerguigue Hounayda, Specialist, Latib Rachida, Professor, El Khannoussi Basma, Professor, Omor Youssef, Professor   +6 more
doaj   +1 more source